Long-term intake of a high prebiotic fiber diet but not high protein reduces metabolic risk after a high fat challenge and uniquely alters gut microbiota and hepatic gene expression

Nutr Res. 2014 Sep;34(9):789-96. doi: 10.1016/j.nutres.2014.08.004. Epub 2014 Aug 23.

Abstract

A mismatch between early developmental diet and adulthood may increase obesity risk. Our objective was to determine the effects of re-matching rats to their weaning diets high in protein or fiber after transient high-fat/high-sucrose challenge in adulthood. We hypothesize that a long-term high fiber diet will be associated with a gut microbiota and hepatic gene expression reflective of reduced adiposity. Wistar rat pups were fed a control (C), high prebiotic fiber (HF), or high protein (HP) diet from 3-15 weeks of age; a high-fat/high-sucrose diet from 15-21 weeks; their respective C, HF, or HP diets from 21-25 weeks. Gut microbiota of cecal contents and hepatic gene expression were measured when rats were terminated at 25 weeks of age. HF rats had higher total bacteria, bifidobacteria and Bacteroides/Prevotella spp than C and HP at 25 weeks (P < 0.05). Firmicutes, especially Clostridium leptum, decreased in HF compared to C and HP (P < .05). The ratio of Firmicutes:Bacteroidetes was markedly lower in HF versus C and HP at 25 weeks (P < .05). HF decreased hepatic cholesterol content compared to HP and C at 25 weeks. HF and HP increased 3-hydroxy-3-methylglutaryl-CoA reductase mRNA and decreased lecithin-cholesterol acyltransferase mRNA compared to C (P < .05). In conclusion, re-matching rats to a HF but not HP diet attenuated the typical increase in Firmicutes:Bacteroidetes ratio associated with consumption of a high fat diet. Lower hepatic cholesterol with long-term HF diet intake may be related to alterations in gut microbiota and hepatic lipid metabolism.

Keywords: Cholesterol; Gut microbiota; Lipid metabolism; Obesity; Prebiotic fiber; Rat.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiposity
  • Animals
  • Bacteria / drug effects
  • Bacteria / growth & development
  • Cecum / microbiology*
  • Cholesterol / metabolism*
  • Diet / adverse effects
  • Diet, High-Fat
  • Dietary Fats / adverse effects*
  • Dietary Fats / metabolism
  • Dietary Fiber / pharmacology
  • Dietary Fiber / therapeutic use*
  • Dietary Proteins / administration & dosage
  • Dietary Proteins / pharmacology*
  • Feeding Behavior
  • Female
  • Gene Expression / drug effects
  • Hydroxymethylglutaryl CoA Reductases / genetics
  • Hydroxymethylglutaryl CoA Reductases / metabolism
  • Lipid Metabolism / drug effects
  • Lipid Metabolism / genetics
  • Liver / drug effects*
  • Liver / metabolism
  • Male
  • Microbiota / drug effects
  • Obesity / metabolism
  • Obesity / prevention & control*
  • Phosphatidylcholine-Sterol O-Acyltransferase / genetics
  • Phosphatidylcholine-Sterol O-Acyltransferase / metabolism
  • Prebiotics
  • RNA, Messenger / metabolism
  • Rats, Wistar
  • Weaning

Substances

  • Dietary Fats
  • Dietary Fiber
  • Dietary Proteins
  • Prebiotics
  • RNA, Messenger
  • Cholesterol
  • Hydroxymethylglutaryl CoA Reductases
  • Phosphatidylcholine-Sterol O-Acyltransferase